Compared with non-invasive ventilation (NIV), high-flow nasal cannula (HFNC) oxygen therapy carried less risk of treatment failure and had better tolerance and comfort among patients. New study ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The available ...

Physicians may consider high-flow nasal cannula (HFNC) as a first-line oxygen therapy in select patients with acute exacerbations chronic obstructive pulmonary disease (AECOPD), according to a study ...

Please provide your email address to receive an email when new articles are posted on . Treating bronchiolitis outside the ICU with weight-based high-flow nasal cannula protocols reduced ICU ...

After high flow nasal cannula oxygen therapy, 15% of patients had to be intubated and mechanically ventilated, but the majority stepped down to regular oxygen therapy. SAN ANTONIO — Elderly patients ...

The complexity of the disease has made ventilator use challenging. Treatment of COVID-19 has been a medical puzzle for front-line doctors largely learning about the disease in real-time without proven ...

Increased capacity anticipated to scale capital production by up to 20X above pre-COVID-19 pandemic levels At maximum capacity, increased production could create up to 350 manufacturing jobs in New ...

The growing role of pediatric intensive care units (PICUs) for managing bronchiolitis in infants and young toddlers over the last decade was associated with increased use of noninvasive respiratory ...

PubMed, EMBASE, CINAHL, Web of Science, Cochrane Library, and Scopus were searched from inception until September 2013 using the following keywords in various combinations: noninvasive ventilation, ...

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary Hi-VNI® Technology products that ...